We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
-0.53%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$261M
AUM Growth
-$12.4M
Cap. Flow
-$6.29M
Cap. Flow %
-2.41%
Top 10 Hldgs %
41.84%
Holding
79
New
3
Increased
8
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$5.17M
2
ILMN icon
Illumina
ILMN
+$5.07M
3
TSLA icon
Tesla
TSLA
+$4.68M
4
MP icon
MP Materials
MP
+$3.5M
5
SLB icon
SLB Ltd
SLB
+$2.77M

Sector Composition

Rank Sector Weight
1 Communication Services 16.18%
2 Consumer Staples 14.66%
3 Healthcare 14.32%
4 Technology 9.5%
5 Consumer Discretionary 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
76
Novo Nordisk
NVO
$208B
-1,700
Closed -$220K
QCOM icon
77
Qualcomm
QCOM
$155B
-1,818
Closed -$308K
REGN icon
78
Regeneron Pharmaceuticals
REGN
$78.5B
-419
Closed -$403K
TSM icon
79
TSMC
TSM
$2.1T
-2,000
Closed -$273K

Similar funds

Sicart Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Sicart Associates held 79 positions worth $261M, down 4.6% from $273M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sicart Associates's Q2 2024 filing shows 3 new, 8 increased, 43 reduced and 7 closed positions. Its largest new stake was Tesla: 26,760 shares worth $5.3M. The largest sale was Meta Platforms (Facebook), an estimated $7.62M.

By sector, the portfolio is most concentrated in Communication Services at 16% of assets, down from 19% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Sicart Associates's largest Q2 2024 buy was Tesla: 26,760 shares worth $5.3M.
  • Sicart Associates added most to iShares Biotechnology ETF in Q2 2024, an estimated $5.17M increase.
  • Sicart Associates's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $7.62M.
  • Sicart Associates fully exited Booking.com in Q2 2024, selling an estimated $2.83M.
  • Sicart Associates's ten largest holdings make up 42% of its $261M portfolio in Q2 2024.
  • Sicart Associates opened 3 new positions and closed 7 in Q2 2024.
  • Sicart Associates's portfolio value fell 4.6% quarter-over-quarter to $261M.

Based on Sicart Associates's 13F filing for Q2 2024, filed 5 Aug 2024.